Data as of Mar 14
| -0.19 / -5.16%|
The 3 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 2.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a -42.69% decrease from the last price of 3.49.
The current consensus among 2 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.